Cargando…

Coronary Artery Disease and Heart Failure With Preserved Ejection Fraction: The ARIC Study

BACKGROUND: Whether coronary artery disease (CAD) is a significant risk factor for heart failure (HF) with preserved ejection fraction (HFpEF) is unclear. METHODS AND RESULTS: Among 9902 participants in the ARIC (Atherosclerosis Risk in Communities) study, we assessed the association of incident CAD...

Descripción completa

Detalles Bibliográficos
Autores principales:	John, Jenine E., Claggett, Brian, Skali, Hicham, Solomon, Scott D., Cunningham, Jonathan W., Matsushita, Kunihiro, Konety, Suma H., Kitzman, Dalane W., Mosley, Thomas H., Clark, Donald, Chang, Patricia P., Shah, Amil M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496411/ https://www.ncbi.nlm.nih.gov/pubmed/36000416 http://dx.doi.org/10.1161/JAHA.121.021660

Ejemplares similares

Association of Undifferentiated Dyspnea in Late Life With Cardiovascular and Noncardiovascular Dysfunction: A Cross-sectional Analysis From the ARIC Study
por: Ramalho, Sergio H. R., et al.
Publicado: (2019)

Pulmonary vascular dysfunction among people aged over 65 years in the community in the Atherosclerosis Risk In Communities (ARIC) Study: A cross-sectional analysis
por: Teramoto, Kanako, et al.
Publicado: (2020)

Depressive Symptoms, Cardiac Structure and Function, and Risk of Incident Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction in Late Life
por: Vu, Katja, et al.
Publicado: (2021)

Predictors of Mortality by Sex and Race in Heart Failure With Preserved Ejection Fraction: ARIC Community Surveillance Study
por: Sharma, Kavita, et al.
Publicado: (2020)

Bidirectional Association Between Frailty and Cardiac Structure and Function: The Atherosclerosis Risk in Communities Study
por: Ramonfaur, Diego, et al.
Publicado: (2023)

Association of Pulmonary Function With Late‐Life Cardiac Function and Heart Failure Risk: The ARIC Study
por: Ramalho, Sergio H. R., et al.
Publicado: (2022)

Heart failure with preserved ejection fraction: New approaches to diagnosis and management
por: Upadhya, Bharathi, et al.
Publicado: (2019)

Prognostic Value of Cardiopulmonary Exercise Testing in Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction
por: Nadruz, Wilson, et al.
Publicado: (2017)

Left Atrial Remodeling and Stroke in Patients With Sinus Rhythm and Normal Ejection Fraction: ARIC‐NCS
por: Bianco, Francesco, et al.
Publicado: (2022)

Subclinical Risk Factors for Heart Failure With Preserved and Reduced Ejection Fraction Among Black Adults
por: Zhao, Li, et al.
Publicado: (2022)

Exercise intolerance in heart failure with preserved ejection fraction: more than a heart problem
por: Upadhya, Bharathi, et al.
Publicado: (2015)

Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study
por: Gori, Mauro, et al.
Publicado: (2016)

Association of Left Atrial Enlargement and Atrial Fibrillation With Cognitive Function and Decline: The ARIC‐NCS
por: Zhang, Michael J., et al.
Publicado: (2019)

Prognostic Value of Minimal Left Atrial Volume in Heart Failure With Preserved Ejection Fraction
por: Shin, Sung‐Hee, et al.
Publicado: (2021)

Impact of Socioeconomic Status on Mortality and Readmission in Patients With Heart Failure With Reduced Ejection Fraction: The ARIC Study
por: Mathews, Lena, et al.
Publicado: (2022)

Associations of Echocardiography Markers and Vascular Brain Lesions: The ARIC Study
por: Johansen, Michelle C., et al.
Publicado: (2018)

Electrocardiographic Predictors of Heart Failure With Reduced Versus Preserved Ejection Fraction: The Multi‐Ethnic Study of Atherosclerosis
por: O'Neal, Wesley T., et al.
Publicado: (2017)

Common Medications and Intracerebral Hemorrhage: The ARIC Study
por: Sharma, Richa, et al.
Publicado: (2021)

Prognostic Importance of Dyspnea for Cardiovascular Outcomes and Mortality in Persons without Prevalent Cardiopulmonary Disease: The Atherosclerosis Risk in Communities Study
por: Santos, Mario, et al.
Publicado: (2016)

Echocardiographic Measures of Cardiac Structure and Function Are Associated with Risk of Atrial Fibrillation in Blacks: The Atherosclerosis Risk in Communities (ARIC) Study
por: Bekwelem, Wobo, et al.
Publicado: (2014)

Skeletal Muscle Mitochondrial Respiration and Exercise Intolerance in Patients With Heart Failure With Preserved Ejection Fraction
por: Scandalis, Lina, et al.
Publicado: (2023)

Effect of Dapagliflozin on 6-Minute Walk Distance in Heart Failure With Preserved Ejection Fraction: PRESERVED-HF
por: Lewis, Gregory D., et al.
Publicado: (2023)

Longitudinal trajectories in renal function before and after heart failure hospitalization among patients with heart failure with preserved ejection fraction in the PARAGON‐HF trial
por: Chatur, Safia, et al.
Publicado: (2022)

Associations Between Atrial Cardiopathy and Cerebral Amyloid: The ARIC‐PET Study
por: Johansen, Michelle C., et al.
Publicado: (2020)

Risk of Dementia Associated With Atrial Cardiopathy: The ARIC Study
por: Johansen, Michelle C., et al.
Publicado: (2022)

Levels and Change in Galectin‐3 and Association With Cardiovascular Events: The ARIC Study
por: Aguilar, David, et al.
Publicado: (2020)

Kidney Disease Measures and Left Ventricular Structure and Function: The Atherosclerosis Risk in Communities Study
por: Matsushita, Kunihiro, et al.
Publicado: (2017)

Cardiac Valve Disease and Prevalent and Incident CKD in Community-Dwelling Older Adults: The Atherosclerosis Risk in Communities (ARIC) Study
por: Karandikar, Vedika M., et al.
Publicado: (2022)

Effects of Sacubitril/Valsartan on Serum Lipids in Heart Failure With Preserved Ejection Fraction
por: Selvaraj, Senthil, et al.
Publicado: (2021)

Ideal Cardiovascular Health and the Prevalence and Severity of Aortic Stenosis in Elderly Patients
por: Sengeløv, Morten, et al.
Publicado: (2018)

Cardiac Structure and Function and Diabetes‐Related Risk of Death or Heart Failure in Older Adults
por: Inciardi, Riccardo M., et al.
Publicado: (2022)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Sacubitril/valsartan and loop diuretic requirement in heart failure with preserved ejection fraction in the PARAGON‐HF trial
por: Chatur, Safia, et al.
Publicado: (2022)

The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
por: Nassif, Michael E., et al.
Publicado: (2021)

Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial
por: Chatur, Safia, et al.
Publicado: (2023)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON‐HF
por: Mooney, Leanne, et al.
Publicado: (2021)

Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials
por: Abdul-Rahim, Azmil H., et al.
Publicado: (2017)

Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)

Plasma phospholipids and prevalence of mild cognitive impairment and/or dementia in the ARIC Neurocognitive Study (ARIC-NCS)
por: Li, Danni, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_p8qg7tf13diofkv1pe54bktrs1